Nasdaq just dealt a huge blow to the cannabis industry

Nasdaq rejected an application by MassRoots, a social network for cannabis users, to list shares on its exchange.

MassRoots said in a press release Tuesday that Nasdaq thinks it’s helping to sell an illegal substance. Medical marijuana is illegal under federal law but allowed in 23 states.

It plans to formally appeal, and has started a public campaign to get more people to protest the electronic exchange.

“If we were a social network for tobacco users or alcohol consumers, the Nasdaq would likely be moving forward on our application even though alcohol and tobacco cause far more deaths and societal damage than cannabis ever will,” said MassRoots CEO Issac Dietrich in a press release following Monday’s denial.

MassRoots would have been the first cannabis-focused company to be listed on the exchange.

“Moreover, the Nasdaq has already listed at least 4 biotechnology companies that extract compounds from the cannabis plant for scientific research — actually touching the plant as part of their business model,” Dietrich said.

Apple banned the MassRoots app from its store, but reinstated it in US states that have legalised medical cannabis.

MassRoots argued that Nasdaq’s decision would make it more difficult for other weed entrepreneurs to raise capital.

We’ve reached out to Nasdaq for comment.

NOW WATCH: You can now have your weed legally delivered in 60 minutes or less with this new app

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at